2-piperidin-1-ium-1-ylethyl N-(4-methoxyphenyl)carbamate,chloride

Names

[ CAS No. ]:
55792-07-9

[ Name ]:
2-piperidin-1-ium-1-ylethyl N-(4-methoxyphenyl)carbamate,chloride

Chemical & Physical Properties

[ Molecular Formula ]:
C15H23ClN2O3

[ Molecular Weight ]:
314.80800

[ Exact Mass ]:
314.14000

[ PSA ]:
50.80000

[ LogP ]:
3.54250

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
FB3973100
CHEMICAL NAME :
Carbamic acid, (4-methoxyphenyl)-, 2-(1-piperidinyl)ethyl ester, monohydrochloride
CAS REGISTRY NUMBER :
55792-07-9
LAST UPDATED :
198511
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C15-H22-N2-O3.Cl-H
MOLECULAR WEIGHT :
314.85

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AFPCAG Acta Facultatis Pharmaceuticae, Universitatis Comenianae. (Ustredna Kniznica Farmaceuticka Fakulta Univerzity Komenskeho, Sasinkova 5, 886 34 Bratislava, Czechoslovakia) V.14- 1967- Volume(issue)/page/year: 29,53,1976

Precursor & DownStream

Precursor

DownStream

  • 2-Piperidinoethanol
  • p-Anisidine

Related Compounds

  • Methyl 3-cyclopropyl-4-ethoxybenzoate
  • 6-(Aminomethyl)-1-methylpyridin-2(1H)-one
  • 4-Pyrimidinemethanamine, N-ethyl-5-(4-ethyl-1-piperazinyl)-2-(1-methylethyl)-
  • 3-(5-Chlorothiophen-2-YL)-4-methyl-1H-pyrazol-5-amine
  • 2-(2-Amino-5-bromopyridine-3-sulfonamido)acetamide
  • 5-[(4-Methyl-1-piperazinyl)sulfonyl]-2-pyrimidinamine
  • 5-Pyrimidinesulfonamide, 2-(methylamino)-N-(1-methylpropyl)-
  • 2-(4-Fluoro-3-methylphenyl)ethan-1-amine
  • 2-{[(9H-fluoren-9-yl)methoxy]carbonyl}-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-1-carboxylic acid
  • 5-Bromo-4-chloro-7-methoxyindoline-2,3-dione
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.